Oxytrol

Intended to manage overactive bladder symptoms to support bladder function.

Strengths: 5mg

Medicine details

Alternative names

Kentera

Therapeutic class

Antispasmodic

Pharmacological class

Anticholinergic

Minor side effects

application site erythema; dry mouth; constipation; pruritus

Moderate side effects

somnolence; blurred vision; nausea; dry eyes

Dosage forms

Transdermal patch

Administration route

Transdermal use

Patient summary

Intended to manage overactive bladder symptoms to support bladder function.

Prescription status

POM

Onset Time

2–4 hours

Duration

3–4 days (per patch)

Storage instructions

Store in original packaging at room temperature.

Drug interactions

other anticholinergics; potassium

Age restrictions

Not recommended for children.

Contraindications

urinary retention; gastric retention; uncontrolled angle-closure glaucoma; myasthenia gravis

Precautions and warnings

avoid prolonged sun exposure; keep the site dry before application; may impair cognitive function in elderly

Serious side effects

anaphylaxis — requires immediate medical attention; urinary retention — requires immediate medical attention

Mechanism of action

Inhibits acetylcholine binding at muscarinic receptors, relaxing bladder smooth muscle to reduce involuntary contractions and urgency.

Pregnancy and breastfeeding

Pregnancy: Use only if potential benefit justifies risk. Breastfeeding: Avoid use.

Oxytrol

Intended to manage overactive bladder symptoms to support bladder function.

Editorial Notes

  • Active ingredient(s): Oxybutynin
  • Listed indication(s): Overactive Bladder

Available option

  • 90 tablets - 5 mg210-5-mg-1338